Sun Pharma’s Leqselvi Faces Legal Obstacles in US Launch Despite FDA Approval
- August 2, 2024
Sun Pharmaceutical Industries Ltd’s new alopecia treatment, Leqselvi (Deuruxolitinib), recently approved by the US Food and Drug Administration (FDA), is encountering legal challenges that may delay its market debut. A motion for
